United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News Cynata Therapeutics secures $8.1m funding after promising results from diabetic foot ulcers trial Cynata Therapeutics Limited, a clinical-stage biotechnology company listed on the Australian Securities Exchange (ASX: CYP), has raised A$8.1… byPallavi MadhirajuDecember 7, 2024